A living replacement knee to be checked in medical trials within 5 years
A group of scientists from Columbia University Irving Medical Center (CUIMC) and Columbia Engineering has actually been granted approximately a $38.95 million agreement from the Advanced Research Projects Agency for Health (ARPA-H) to develop a living knee replacement from biomaterials and human stem cells, consisting of a client's own cells. ARPA-H is a federal financing firm that funds transformative biomedical and health research study developments, quickly equating research study from the laboratory to applications in the market.
The Award
The award, part of the ARPA-H's Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO) program, will support the advancement of NOVAJoint, an innovative biocompatible, low-priced, patient-specific knee joint replacement. Th...